This disclosure relates to heart valve repair, such as mitral valve repair.
Patient conditions associated with heart valves can produce valvular insufficiency or regurgitation. Valvular insufficiency or regurgitation occurs when a valve in a heart of a subject does not close completely, allowing blood to flow backwards (e.g., from the left ventricle to the left atrium), which may adversely impact the functionality of the heart.
The mitral valve includes two leaflets (anterior and posterior) attached to an annulus (e.g., a fibrous ring). In a healthy heart, the mitral valve leaflets close during contraction of the left ventricle and prevent blood from flowing back into the left atrium. Mitral valve regurgitation is a condition in which the leaflets of a mitral valve of a subject do not coapt properly and, as a result, blood regurgitates back into the left atrium from the left ventricle. The regurgitation of blood back into the left atrium may result in a reduced ejection volume from the left ventricle, causing the heart of the subject to work relatively hard to supply the desirable volume of blood to the body. Mitral regurgitation may occur because of different patient conditions. For example, secondary mitral regurgitation, also referred to as functional mitral regurgitation, may occur when a left ventricle dilates and causes dilation of the mitral annulus of a subject.
Some aspects of this disclosure describe examples of annuloplasty devices, systems, and methods for treating and/or repairing a heart valve, including, but not limited to, a mitral valve. The annuloplasty devices, systems, and techniques may enable reduction in spacing between valve leaflets, may improve coaptation of the valve leaflets, and may help reduce valvular insufficiency or regurgitation. Some examples described herein employ a minimalistic approach to septal-lateral cinching, e.g., of the mitral valve, through the use of a transcatheter, trans-septal approach for deploying an annuloplasty device. In some examples, one or more flexible elongated elements are attached to one or more anchors proximate the lateral side of a valve annulus and then tightened to pull the lateral side of the annulus closer to the anterior side of the annulus, thus reducing the septal-lateral dimension of the annulus. In some examples, an annuloplasty system includes an annuloplasty ring with a permanently deformable section, that when deformed after implantation, changes the dimensions of a corresponding valve annulus.
In some examples, the disclosure is directed to an annuloplasty system that includes an elongated flexible element including a proximal portion and a distal portion. The annuloplasty system includes at least one anchor configured to secure the elongated flexible element proximate an annulus of a cardiac or vascular valve. The annuloplasty system also includes a closure device configured to close a delivery opening in a tissue wall and secure the proximal and distal portions of the elongated flexible element. The elongated flexible element and the at least one anchor are configured to be delivered to the cardiac or vascular valve through the delivery opening in the tissue wall. In some examples, securing the proximal and distal portions of the elongated flexible element with the closure device pulls the at least one anchor and a portion of the annulus toward the closure device, thereby decreasing a width of the annulus.
In some examples, the disclosure is directed to an annuloplasty system that includes an elongated flexible element comprising a proximal portion, a distal portion, and an intermediate portion between the proximal and distal portions, and first, second, and third anchors. The first anchor is configured to secure the proximal portion of the elongated flexible element to a first tissue site adjacent a cardiac or vascular valve annulus. The second anchor is configured to secure the distal portion of the elongated flexible element to a second tissue site adjacent the cardiac or vascular valve annulus. The third anchor is configured to secure the intermediate portion of the elongated flexible element proximate the valve annulus. At least one of the first, second, and third anchors includes a rotatable portion configured to receive and/or attach to a portion of the elongated flexible element. Turning the rotatable portion winds the portion of the elongated flexible element about the rotatable portion, thereby decreasing a length of the elongated flexible member between the first anchor and the third anchor, and/or decreasing a length of the elongated flexible member between the second anchor and the third anchor so as to pull the third anchor and a portion of the annulus toward the first and second anchors, thereby decreasing a width of the annulus.
In some examples, the disclosure is directed to an annuloplasty system that includes an elongated flexible element including a proximal portion and a distal portion. The annuloplasty system further includes a first anchor configured to secure the proximal portion of the elongated flexible element proximate a cardiac or vascular valve annulus on a first side of the valve. The annuloplasty system further includes a second anchor configured to secure the elongated flexible element proximate the valve annulus on a second side of the valve apart from the first side. The first and/or second anchor and/or the distal portion of the elongated flexible element are configured such that the distal portion of the elongated flexible element can pass through a portion of the first and/or second anchor in a first direction but cannot be retracted through the first and/or second anchor in an opposite second direction, such that pulling the flexible element through the first and/or second anchor shortens a distance between the first and second anchors, thereby decreasing a width of the annulus.
In some examples, the disclosure is directed to an annuloplasty system including an elongated flexible element, a first anchor and a second anchor. The elongated flexible element includes a proximal portion and a distal portion. The first anchor is configured to secure the proximal portion of the elongated flexible element at a first location about a cardiac or vascular valve annulus. The second anchor is configured to secure the elongated flexible element at a second location about the valve annulus apart from the first location. In some examples the first anchor and/or the distal portion of the elongated flexible element are configured such that the distal portion of the elongated flexible element can pass through a portion of the first anchor in a first direction but cannot be retracted through the first anchor in an opposite second direction, such that pulling the flexible element through the first anchor shortens a distance between the first and second anchors, thereby decreasing a width of the annulus.
In some examples, the disclosure is directed to an annuloplasty system including a first annuloplasty device and a second annuloplasty device, where each of the first and second annuloplasty devices includes an elongated flexible element, a first anchor, and a second anchor. The elongated flexible element includes a proximal portion and a distal portion. The first anchor is configured to secure the proximal portion of the elongated flexible element at a first location about a cardiac or vascular valve annulus. The second anchor is configured to secure the elongated flexible element at a second location about the valve annulus apart from the first location. In some examples, the first anchor and/or the distal portion of the elongated flexible element are configured such that the distal portion of the elongated flexible element can pass through a portion of the first anchor in a first direction but cannot be retracted through the first anchor in an opposite second direction, such that pulling the flexible element through the first anchor shortens a distance between the first and second anchors, thereby decreasing a width of annulus. In some examples, the first and second annuloplasty devices operate independently and are anchored to separate portions of the valve annulus.
In some examples, the disclosure is directed to an annuloplasty system including an annuloplasty ring and a plurality of movable joints. The annuloplasty ring includes first, second, and third ring portions, and a plurality of anchors configured to secure the first, second, and third portions proximate to a cardiac or vascular valve annulus. The movable joints join the third ring portion together with the first and second ring portions. The third ring portion includes a permanently deformable material. Deforming the third ring portion pulls together the first and second ring portions, thereby decreasing the diameter of the annuloplasty ring and a corresponding width of the valve annulus.
In some examples, the disclosure is directed to a method for repairing a cardiac or vascular valve. The method includes advancing a delivery device through vasculature of a patient to a treatment site such as, for example, a cardiac or vascular valve. The method also includes releasing an annuloplasty device from the delivery device. The annuloplasty device includes at least one anchor. The method also includes attaching the at least one anchor to tissue proximate to an annulus of the valve. The method also includes cinching the annuloplasty device to decrease a width of the valve annulus.
The details of one or more examples are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of examples according to this disclosure will be apparent from the description and drawings, and from the claims.
This disclosure describes annuloplasty devices, systems, and techniques for repairing a heart valve, such as, but not limited to, a mitral valve.
The annuloplasty devices, systems, and techniques described herein generally may enable reduction in spacing between valve leaflets, may improve coaptation of the valve leaflets, and may help reduce valvular insufficiency or regurgitation. While examples of the disclosure are described primarily with regard to treatment of the mitral valve, treatment of other heart valves is also contemplated.
The left atrium LA receives oxygenated blood from the lungs via the pulmonary veins and pumps the oxygenated blood through the mitral valve MV and into the left ventricle LV during ventricular diastole. The left ventricle LV contracts during systole and blood flows outwardly through the aortic valve AV, into the aorta and to the remainder of the body. In a healthy heart, the leaflets LF of the native mitral valve MV meet evenly at the free edges or “coapt” to close and prevent back flow of blood into the left atrium LA during contraction of the left ventricle LV. The tissue of the leaflets LF attach to the surrounding heart structure via a dense fibrous ring of connective tissue called an annulus AN. The flexible tissue of the leaflets LF of the native mitral valve MV are connected to papillary muscles PM, which extend upwardly from the lower wall of the left ventricle LV and the interventricular septum IVS, via branching tendons called chordae tendineae CT.
Mitral valve regurgitation is a condition in which the leaflets of a mitral valve of a subject do not coapt properly and, as a result, blood regurgitates back into the left atrium LA from the left ventricle LV. The regurgitation of blood back into the left atrium LA may result in a reduced ejection volume from the left ventricle LV, causing the heart of the subject to work relatively hard to supply the desirable volume of blood to the body. Mitral regurgitation may occur because of one or more patient conditions. For example, secondary mitral regurgitation, also referred to as functional mitral regurgitation, may occur when the left ventricle LV dilates and causes dilation of the mitral annulus of a subject. The leaflets LF of the valves may move apart as a result of the dilation of the left ventricle LV, which may adversely impact the ability of the leaflets to properly coapt.
In addition to or instead of being caused by dilation of the left ventricle LV, mitral valve regurgitation (or other valve regurgitation) may be caused by calcified plaque buildup in heart 10. For example, the leaflets LF of the valves (e.g., aortic valve AV or mitral valve MV) may harden and may not sufficiently coapt or meet, such that regurgitation may occur where the valve does not close completely, allowing blood to flow backwards (e.g., from the left ventricle LV to the left atrium LA). The left side of heart 10 (e.g., mitral valve MV and aortic valve AV) can be more likely to become calcified because of the higher pressures generated.
In some examples, heart 10 may suffer from Secondary Mitral Regurgitation, or Functional Mitral Regurgitation (FMR). Secondary Mitral Regurgitation or FMR may occur when a diseased left ventricle dilates and causes the dilation of the mitral annulus. This dilation does not allow the leaflets to coapt appropriately, and blood will be regurgitated back into the left atrium, causing the heart to work even harder to appropriately supply blood to the body.
In some examples, a surgical technique may be used to implant a ring on the annulus, referred to as annuloplasty. A goal of annuloplasty in FMR patients may be to reduce the distance between the two leaflets, or the septal-lateral annular diameter. Such open-heart surgery can be difficult for patients who are already very sick, and physicians are looking for a less invasive way to treat. The annuloplasty devices, systems, and techniques described herein may be used to repair a valve of heart 10 via a minimally invasive or relatively non-invasive medical procedure, e.g., via a transcatheter, trans-septal medical procedure that is less invasive than open heart surgery. While open heart surgeries, such as annuloplasty performed via open heart surgery, may have positive outcomes, a more minimally invasive medical procedure may be associated with a shorter recovery time for some patients.
In some examples an annuloplasty system is designed or configured to include multiple (e.g., 2, 3-5, or more) anchors around a lateral side of a valve annulus. In some examples the anchors can be screws, nitinol, or another type of anchoring system. The anchors are attached through an elongated flexible element such as, for example, a suture or wire. In an example using a wire, the ends of the wire are pulled tight, which pulls the lateral side of the annulus towards a delivery hole in the septum, thereby reducing the septal-lateral diameter of the annulus. The wire (or, e.g., suture) can then be locked in place with a closure device in the septum. The hole in the septum may in some circumstances be considered a potential risk for clinical outcomes. Accordingly, the closure device can in some examples serve two purposes: maintaining the cinch across the annulus in the appropriate direction, and closing the hole created in the septum for delivery of the system components.
As shown in
After pulling the lateral side toward the atrial septum by a desired amount, ends 50, 52 of flexible element 48 are locked in place with closure device 54 placed in delivery hole 42 in septum 44. Accordingly, in the example shown in
Anchors 46 are configured to insert into the heart tissue and remain in place in the presence of the opposing force from flexible element 48. In some examples, anchors 46 each include a helix or double helix that is configured to be advanced into tissue of heart 10. For example, an anchor may be spirally advanced in the posterior, e.g., lateral, portion of annulus 22 and/or into posterior leaflet 26. The helix or double helix may optionally include an attachment, such as a hook, loop, or the like that is configured to receive and/or attach to flexible element 48 so that tension applied to flexible element 48 acts on the anchor and the surrounding tissue. In some examples, anchors 46 are formed as screws and/or may include a biocompatible metal or alloy, such as nitinol, stainless steel, a cobalt-chromium alloy, or the like. In some examples, anchors 46 can include features similar to one or more features provided by the implant system available from Medtronic, Inc., Minneapolis, Minn., under the name Heli-FX™ EndoAnchor™.
The example illustrated in
Elongated flexible element 48 is configured to be deployed and remain within example heart 10, and accordingly includes a suitable biocompatible material. In some examples, flexible element 48 includes a suture or a wire configured to cinch mitral annulus 22. Some examples of possible materials and configurations for flexible element 48 include a monofilament, a braid of a plurality of filaments of the same or material or of filaments from different materials, a braided sheath with a single filament core, and/or a braided sheath with a braided core. In some cases, the flexible element may be composed of a biocompatible material such as, but not limited to, nylon or polyester. In some examples, a flexible element can be formed at least in part from a material that does not stretch. In some cases, a flexible element may be pre-stressed to prevent the flexible element from elongating after the annuloplasty device 40 is implanted. One example of a suitable material includes a pre-stretched ultra-high-molecular-weight polyethylene.
In some examples, the catheter may be used with a guidewire, a guide catheter, or the like, to facilitate introduction of the catheter into vasculature of a patient and advancing of the distal end of the catheter to the treatment location. In some examples, the catheter includes a steerable shaft and/or distal tip to allow a clinician to control positioning of the distal tip relative to anatomical structures, such as heart 10. In some examples, a delivery system may include a steerable guide and/or a catheter-based torque member similar to the steerable guide and/or application device provided with the implant system available from Medtronic, Inc., Minneapolis, Minn., under the name Heli-FX™ EndoAnchor™.
In some examples, to facilitate positioning of the delivery device, e.g., the catheter, the annuloplasty device 40, or both, within the treatment location, a distal portion of the catheter may include at least one radiographic marker configured to be visualized using a radiographic technique.
In some examples, the catheter may access the left atrium LA trans-septally. For example, as shown in
Delivery device 56 (e.g., the catheter of
While the description of a delivery system has been provided above with reference to delivery device 56 in
In some examples, one of the first, second, and third anchors can be configured to adjustably secure a portion of flexible element 62. For example, the third anchor 68 can be configured to adjustably secure flexible element 62. In some examples, the third anchor 68 may include a first portion, such as a screw or tine, that is inserted into the heart tissue. A second portion of the anchor 68 may swivel or turn with respect to the first portion (e.g., as indicated by the arrow at anchor 68). During deployment, flexible element 62 becomes tighter, effectively shortening as it winds around the turning second portion of third anchor 68. The tightening and shortening flexible element 62 cinches the mitral annulus as shown in
In some examples, the anchors and flexible element shown in
In some examples an annuloplasty system includes one, two, three, or more sets of flexible elements and anchors that can be implanted at multiple locations about a cardiac or vascular valve. Using one, two or more sets of flexible elements and anchors can enable a further customized treatment that may depend on, e.g., a specific patient anatomy and/or diametric reduction need. In some examples two or more flexible elements in parallel with each other across the valve in, e.g., a septal-lateral or anterior/posterior direction.
In the example shown in
The first flexible element 82 includes a first cinching anchor 88 and the second flexible element 84 includes a second cinching anchor 90. As with the example illustrated in
Some examples of the annuloplasty device 100 are configured to re-dimension the device ring by deforming a portion of the ring. As an example, in
Delivery device 56 may be advanced through vasculature of a patient of a treatment site (122). For example, a clinician may introduce delivery device 56 into vasculature of a patient transcutaneously. For instance, the delivery device 56 may be introduced to a femoral or radial artery. The delivery device 56 may be advanced through vasculature of the patient to the treatment site by a clinician manipulating a handle of delivery device 56. In some examples, the delivery device 56 may include a steerable shaft or tip to allow the clinician to direct delivery device 56 through bends, curves, and branching points of the vasculature.
As shown in
Once the delivery device 56 (e.g., a distal portion of the delivery device 56) has been advanced to the treatment site, the delivery device 56 may release the annuloplasty device 40, including flexible element 48 and the anchors 46 (124). The particular way in which the annuloplasty device 40 is released by the delivery device 56 may depend on the configuration of the annuloplasty device 40. Releasing the annuloplasty device 40 may include, for example, moving the anchors 46 between an undeployed configuration in which the anchors extends generally inward into the catheter and a deployed configuration in which the anchors extend generally outward away from the catheter.
After releasing the annuloplasty device 40, the anchors 46 are attached to the lateral or posterior side of the annulus, e.g., in the configuration shown in
After implanting first anchor 138, the delivery system moves second anchor 140 to another site for deployment. Although two anchors are shown in
Various examples have been described. These and other examples are within the scope of the following claims.
This application claims the benefit of U.S. Provisional Application Ser. No. 62/779,294, entitled “HEART VALVE REPAIR,” and filed on Dec. 13, 2018, the entire content of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62779294 | Dec 2018 | US |